Loading...
Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus
New human cytomegalovirus (HCMV) therapies with novel mechanisms of action are needed to treat drug-resistant HCMV that arises during therapy with currently approved agents. 2-Bromo-5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (BDCRB) is an effective anti-HCMV agent with a novel mechanism of ac...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
2004
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC400548/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15105116/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.5.1647-1651.2004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|